9 participants
Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-03-12
- Start Date:
- 2019-10-07
- Completion:
- 2023-01-09
Conditions
- Relapsed/Refractory Multiple Myeloma
Interventions
- DRUG